Pharmacokinetics, Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara (Ustekinumab)
Condition(s):PsoriasisLast Updated:May 23, 2022Completed
Hide Studies Not Open or Pending
Condition(s):PsoriasisLast Updated:May 23, 2022Completed
Condition(s):PsoriasisLast Updated:January 11, 2024Completed
Condition(s):Lupus Erythematosus, SystemicLast Updated:March 24, 2020Completed
Condition(s):PsoriasisLast Updated:November 1, 2021Completed
Condition(s):Ulcerative ColitisLast Updated:January 3, 2024Completed
Condition(s):Polymyositis; DermatomyositisLast Updated:August 11, 2022Terminated
Condition(s):Behçet DiseaseLast Updated:November 22, 2021Completed
Condition(s):Palmo-Plantar Pustular Psoriasis; Palmo-Plantar PustulosisLast Updated:June 11, 2013Terminated
Condition(s):Crohn DiseaseLast Updated:February 28, 2024Active, not recruiting
Condition(s):Crohn’s DiseaseLast Updated:July 19, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.